Get started

Financials · MLSS

Milestone Scientific Inc. (MLSS) financials

For the twelve months ended Jun 30, 2026, Milestone Scientific Inc. reported $9.42M of revenue and -$4.14M of net income.

Revenue, TTM
$9.42M
Revenue growth, YoY
+3.7%
Net income, TTM
-$4.14M
Net margin
-44.0%
Free cash flow, TTM
-$657.8K
EPS, diluted, TTM
-$0.05
Cash
$2.07M
Total debt
$466.0K
P/S
2.93
Market cap
$27.6M
Annual revenue$8.97M
FY2017FY2025
Annual net income-$5.72M
FY2016FY2025
Annual free cash flow-$2.93M
FY2016FY2025

MLSS revenue and earnings growth

MLSS revenueQ2 2026$2.84M

Quarter YoY
+22.3%
QoQ
+31.4%
FY YoY
+4.0%
5Y CAGR
+10.5%

MLSS revenue was $2.84M in fiscal Q2 2026 (ended Jun 30, 2026), up 22.3% from a year earlier and up 31.4% from the prior quarter. For the full fiscal 2025 it was $8.97M, up 4.0% from fiscal 2024. Compound annual growth was +10.5% over 5 years. It rose in 3 of the last 8 fiscal years.

MLSS net incomeQ2 2026-$1.06M

MLSS net income was -$1.06M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$1.48M a year earlier. For the full fiscal 2025 it was -$5.72M, compared with -$4.71M in fiscal 2024.

MLSS EPSQ2 2026-$0.01

MLSS diluted EPS was -$0.01 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.02 a year earlier. For the full fiscal 2025 it was -$0.07, compared with -$0.06 in fiscal 2024.

MLSS free cash flowQ2 2026-$589.3K

MLSS free cash flow was -$589.3K in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$1.77M a year earlier. For the full fiscal 2025 it was -$2.93M, compared with -$2.93M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$8.97M$8.63M$9.83M$8.81M$10.30M$5.44M$8.37M$9.62M$11.28M-
Cost of revenue$2.57M$2.20M$3.03M$3.91M$3.99M$1.82M$2.66M$5.19M$4.31M$4.18M
Gross profit$6.41M$6.43M$6.79M$4.90M$6.31M$3.62M$5.72M$4.43M$6.97M$6.31M
Research and development$449.5K$858.8K$701.4K$1.15M$878.2K$307.9K$189.9K$245.6K$272.7K$1.27M
Selling, general and admin$11.58M$12.30M$13.14M$12.51M$12.74M$10.67M$9.53M$10.65M$11.93M$11.55M
Operating income-$5.70M-$6.76M-$7.11M-$8.83M-$7.38M-$7.45M-$4.00M-$8.00M-$5.23M-$6.51M
Pre-tax income-$5.72M-$4.71M-$6.98M-$8.77M-$7.12M-$7.47M-$7.64M-$8.00M-$5.23M-$6.52M
Income tax--$0$0$333$15.5K$18.1K$24.0K$19.1K-$19.1K
Net income-$5.72M-$4.71M-$6.93M-$8.71M-$6.82M-$7.34M-$7.52M-$7.43M-$5.19M-$5.95M
EPS, basic-$0.07-$0.06-$0.10-$0.12-$0.10-$0.12-$0.16-$0.21-$0.16-$0.22
EPS, diluted-$0.07-$0.06---$0.10-$0.12-$0.16-$0.21-$0.16-$0.22
Diluted shares82.1M79.8M--68.8M63.1M45.7M35.3M32.7M27.0M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$1.11M$3.26M$2.98M$8.72M$14.76M$14.22M$1.52M$2.00M$2.64M$3.60M
Short-term investments-$0$2.98M$0$14.80M$13.10M$302.0K---
Receivables-$475.4K$312.7K$693.7K$943.3K$1.08M$1.71M$1.98M$1.54M$802.4K
Inventory$3.78M$3.71M$2.64M$1.79M$1.54M$2.42M$1.62M$1.92M$3.38M$4.60M
Current assets$7.48M$9.29M$10.79M$12.97M$18.93M$18.55M$6.08M$5.86M$12.02M$13.34M
Total assets$7.81M$9.80M$11.37M$13.70M$19.81M$19.57M$6.56M$6.40M$15.63M$14.18M
Current liabilities$4.13M$3.74M$3.08M$3.30M$3.10M$2.88M$4.93M$4.87M$6.73M$5.65M
Long-term debt$800.0K---------
Total debt$800.0K---------
Total liabilities$4.99M$3.96M$3.36M$3.70M$3.59M$3.46M$4.93M$4.87M$8.13M$5.65M
Shareholders' equity$2.81M$5.83M$8.01M$10.01M$16.22M$16.11M$1.63M$1.53M$7.50M$8.54M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$2.92M-$2.92M-$5.33M-$6.03M-$4.03M-$6.98M-$1.78M-$1.63M-$1.23M-$5.40M
Capital expenditures$15.1K$10.1K-$8.5K$15.2K$21.4K$9.9K$7.4K$6.0K$15.3K
Free cash flow-$2.93M-$2.93M--$6.04M-$4.05M-$7.01M-$1.79M-$1.64M-$1.24M-$5.41M
Investing cash flow-$15.1K$2.97M-$2.97M-$8.5K-$15.2K-$21.4K-$9.9K-$15.4K-$199.2K$8.2K
Financing cash flow$786.3K$233.8K$2.56M-$8.5K$4.59M$19.71M$2.56M-$250.0K$463.3K$4.80M
Stock-based compensation$952.7K$1.35M$1.47M$1.50M$790.9K$550.3K$183.9K$409.0K$651.4K$1.85M
Depreciation and amortization$78.2K$37.4K$61.9K$63.8K$73.8K$95.9K$100.5K$881.3K$573.1K-

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY4.0%-12.2%11.6%-14.5%89.5%-35.1%-13.0%-14.7%--
Gross margin71.4%74.6%69.1%55.7%61.3%66.6%68.3%46.1%61.8%-
Operating margin-63.5%-78.3%-72.3%-100.2%-71.6%-137.1%-47.8%-83.1%-46.4%-
Net margin-63.8%-54.6%-70.5%-98.9%-66.2%-134.9%-89.8%-77.2%-46.0%-
Free cash flow margin-32.7%-34.0%--68.6%-39.3%-128.9%-21.4%-17.0%-11.0%-
Return on equity-203.4%-80.8%-86.5%-87.0%-42.0%-45.6%-462.0%-486.3%-69.2%-69.7%
Return on assets-73.3%-48.1%-60.9%-63.5%-34.4%-37.5%-114.8%-116.1%-33.2%-41.9%
Current ratio1.812.483.513.936.116.451.231.201.792.36
Debt to equity0.28---------

Source: XBRL data Milestone Scientific Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

MLSS peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
MLSS$9.42M+3.7%-$4.14M-44.0%$27.6M
ISRG$11.58B+20.5%$2.96B25.5%$159.65B
EW$6.67B+13.4%$1.02B15.3%$60.21B
STE$6.17B+8.1%$826.90M13.4%$24.95B
ZBH$8.57B+7.0%$767.30M9.0%$20.50B
MAS$7.67B+0.9%$926.00M12.1%$16.56B
SNN$6.16B+6.1%$625.00M10.1%$13.00B
ALGN$4.16B+4.4%$491.87M11.8%$12.28B
AIT$5.06B+8.5%$424.12M8.4%$10.86B

MLSS FAQ

9 questions
  • What is MLSS revenue?
    Milestone Scientific Inc. (MLSS) reported $9.42M of revenue for the twelve months ended Jun 30, 2026. That is up 3.7% from the year before. Revenue for fiscal 2025 was $8.97M.
  • Is MLSS profitable?
    No. Milestone Scientific Inc. reported a net loss of $4.14M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does MLSS have?
    Milestone Scientific Inc. reported $2.07M in cash and cash equivalents and $466.0K of debt on its most recent balance sheet in SEC filings.
  • How fast is MLSS revenue growing?
    Milestone Scientific Inc.'s revenue changed +4.0% in fiscal 2025, to $8.97M. Its compound annual growth rate was +10.5% over 5 years.
  • What is MLSS gross margin?
    Milestone Scientific Inc.'s gross profit was $6.62M on $9.42M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 70.2%.
  • What is MLSS free cash flow?
    Milestone Scientific Inc. generated -$657.8K of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$642.6K less capital expenditures.
  • What is MLSS earnings per share?
    Diluted earnings per share were -$0.05 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did MLSS last report financial results?
    The latest statements here come from Milestone Scientific Inc.'s 10-Q filed on Aug 13, 2026, covering the period ended Jun 30, 2026.
  • Where does this MLSS financial data come from?
    Quantisnow builds these statements from the structured XBRL data Milestone Scientific Inc. files with the SEC. It is provided for information only and is not investment advice.